ASSETS	December 31,  2003			June 30, 2003
CURRENT ASSETS:
Cash and cash equivalents	$	3,847,088		$	3,716,446
Accounts receivable, less allowance for doubtful accounts
of $350,000 and $300,000, respectively		7,561,723			5,627,198
Other receivables		421,556			553,147
Inventories		5,951,460			6,347,208
Prepaid expenses		252,065			340,934
Total current assets		18,033,892			16,584,933
Property, plant and equipment – net		2,079,728			2,093,408
License rights and patents – net		80,485			83,986
TOTAL ASSETS	$	20,194,105		$	18,762,327
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable	$	3,094,461		$	2,272,953
Accrued liabilities:
Compensation and commissions		929,942			850,034
Product warranties		420,321			312,000
Other		305,492			254,470
Total current liabilities		4,750,216			3,689,457
OTHER LONG-TERM OBLIGATIONS		31,953			38,662
TOTAL LIABILITIES		4,782,169			3,728,119
STOCKHOLDERS' EQUITY:
Preferred stock - $.04 par value, 500,000 shares authorized
no shares issued or outstanding		—			—
Common stock - $.04 par value, 15,000,000 shares authorized, 11,404,874
shares issued, and 11,277,541 and 11,073,832 outstanding, respectively		456,195			448,161
Additional paid-in capital		23,703,918			23,360,244
Common stock held in treasury (127,333 and 130,192 shares, respectively)		(414,292	)		(419,618	)
Subscriptions receivable		(225,000	)		(225,000	)
Retained earnings (accumulated deficit)		(8,105,403	)		(8,126,097	)
Cumulative translation adjustment		(3,482	)		(3,482	)
Total stockholders' equity		15,411,936			15,034,208
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	20,194,105		$	18,762,327

	2

	2003			2002
NET SALES	$	15,352,694		$	15,353,953
COST OF GOODS SOLD		9,093,679			9,018,466
GROSS PROFIT		6,259,015			6,335,487
OPERATING EXPENSES:
Sales and marketing		3,372,216			3,341,298
Research, development and engineering		1,224,313			1,385,655
Administrative		1,725,051			2,088,761
Total		6,321,580			6,815,714
LOSS FROM OPERATIONS		(62,565	)		(480,227	)
OTHER INCOME (EXPENSE):
Interest expense		—			(91,533	)
Interest income		20,749			28,528
Other		62,510			431,752
Total		83,259			368,747
INCOME (LOSS) BEFORE INCOME TAXES		20,694			(111,480	)
INCOME TAX PROVISION		—			—
NET INCOME (LOSS)	$	20,694		$	(111,480	)
NET INCOME (LOSS) PER COMMON SHARE:
Basic	$	0.00		$	(0.01	)
Diluted	$	0.00		$	(0.01	)
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING:
Basic		11,098,339			11,071,264
Diluted		11,432,539			11,071,264

	3

	2003			2002
NET SALES	$	8,980,277		$	9,049,606
COST OF GOODS SOLD		5,295,668			5,111,466
GROSS PROFIT		3,684,609			3,938,140
OPERATING EXPENSES:
Sales and marketing		1,864,770			2,014,338
Research, development and engineering		623,721			756,715
Administrative		823,793			1,131,531
Total		3,312,284			3,902,584
INCOME FROM OPERATIONS		372,325			35,556
OTHER INCOME (EXPENSE):
Interest expense		—			—
Interest income		11,009			12,662
Other		29,090			131,953
Total		40,099			144,615
INCOME BEFORE INCOME TAXES		412,424			180,171
INCOME TAX PROVISION		—			—
NET INCOME	$	412,424		$	180,171
NET INCOME PER COMMON SHARE:
Basic	$	0.04		$	0.02
Diluted	$	0.04		$	0.02
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING:
Basic		11,121,941			11,069,846
Diluted		11,475,656			11,382,915

	4

	2003			2002
OPERATING ACTIVITIES:
Net income (loss)	$	20,694		$	(111,480	)
Adjustments to reconcile net income (loss) to net cash
provided by operating activities:
Depreciation		282,897			453,725
Amortization		3,501			3,500
Provision for doubtful accounts		52,442			—
Provision for obsolete inventory		353,103			(177,813	)
Gain on sale of Immtech stock		—			(255,843	)
Gain on sale of building		—			(41,208	)
Changes in assets and liabilities:
Accounts receivable		(1,986,967	)		(875,230	)
Other receivables		131,591			97,786
Inventories		17,700			(145,120	)
Prepaid expenses		88,869			122,080
Accounts payable		821,508			1,275,323
Accrued liabilities		232,542			146,219
Net cash provided by operating activities		17,880			491,939
INVESTING ACTIVITIES:
Purchases of property, plant and equipment, net		(244,272	)		(557,597	)
Proceeds from sale of Immtech stock		—			255,843
Proceeds from sale of building		—			3,795,164
Net cash (used in) provided by investing activities		(244,272	)		3,493,410
FINANCING ACTIVITIES:
Retirement of long-term debt		—			(3,197,125	)
Repurchase of Company common stock		—			(121,359	)
Proceeds from issuance of common stock		357,034			13,364
Net cash provided by (used in) financing activities		357,034			(3,305,120	)
EFFECT OF EXCHANGE RATE CHANGES ON CASH		—			268
NET INCREASE IN CASH AND CASH EQUIVALENTS		130,642			680,497
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR		3,716,446			3,523,070
CASH AND CASH EQUIVALENTS, END OF YEAR	$	3,847,088		$	4,203,567

	5

	6

	7

6. Guarantees

Criticare Integration, Inc., a wholly owned U.S. subsidiary of the Company, was incorporated on April 8, 2003 to supply medical equipment and supplies to medical facilities in countries in the Black Sea Economic Zone (Albania, Armenia, Azerbaijan, Bulgaria, Georgia, Romania, and the Ukraine). The Company had set up a standby letter of credit for $300,000 on behalf of a Romanian company it is working with in connection with this new venture. The standby letter of credit served as a guarantee for a $2,000,000 line of credit that had been extended by a large Austrian bank to the Romanian company to fund this project. The standby letter of credit was to expire on November 15, 2003. The line of credit was no longer deemed necessary to fund the project and was therefore cancelled prior to expiration. The related standby letter of credit from the Company guaranteeing the line of credit was also cancelled on October 2 0, 2003.

The Company also maintained a second standby letter of credit (SBLC) for $300,000 on behalf of the Romanian company that served as a guarantee to fund borrowings by the Romanian company used to set up and market this project. This SBLC was to expire on November 1, 2003, but was renewed through November 1, 2004 on October 16, 2003. Due mainly to more favorable credit terms obtained from another bank, on December 24, 2003 this $300,000 SBLC was cancelled and replaced by a $400,000 SBLC from another bank that expires on December 31, 2004. This standby letter of credit would only be called if the cash flows from the project were not adequate to fund the costs to support the project and the Romanian company would not be able to retire the debt.

In the fiscal second quarter ended December 31, 2003, the Company also set up two new standby letters of credit to two suppliers of medical equipment for the project totaling $100,000. These two SBLC’s were set up to secure payment for the suppliers and would only be called if the cash flows from the project were not adequate to fund equipment purchases from these suppliers. The value of these three guarantees that were issued in the current fiscal quarter were not material to the Company’s financial statements.

7. Stock Options

The Company has adopted the disclosure-only provisions of SFAS No. 123, “Accounting for Stock-Based Compensation” and SFAS No. 148, “Accounting for Stock-Based Compensation—Transition and Disclosure.” If the Company had elected to recognize compensation cost for the options granted for the three months and six months ended December 31, 2003 and 2002, consistent with the method prescribed by SFAS No. 123, net income (loss) and net income (loss) per share would have been changed to the pro forma amounts indicated below:

 

	Three Months Ended						Six Months Ended
	2003			2002			2003			2002
Net income (loss) – as reported	$	412,424		$	180,171		$	20,694		$	(111,480	)
Net income (loss) – pro forma	$	407,613		$	180,171		$	14,049		$	(111,480	)
Basic and diluted net income (loss) per     share – as reported	$	0.04		$	0.02		$	0.00		$	(0.01	)
Basic and diluted net income (loss) per     share – pro forma	$	0.04		$	0.02		$	0.00		$	(0.01	)

 

The fair value of stock options used to compute pro forma net income (loss) and net income (loss) per share is the estimated present value at the grant date using the Black-Scholes option-pricing model.

 

 

	8

8. Income Taxes

No income tax provision has been made in the consolidated income statements due to federal and state net operating loss carry forwards that will be utilized to offset taxable income earned. At December 31, 2003, the Company had federal net operating loss carry forwards of approximately $13,361,000 (which expire from 2008 through 2023) and state net operating loss carry forwards of approximately $10,037,000 (which expire from 2004 through 2018) available to offset future taxable income. The Company has recorded a valuation allowance to offset the related deferred income tax assets arising from these net loss carry forwards due to the uncertainty of realizing the benefits of these assets in future years.

9. Commitment

On January 19, 2004 the Company entered into a lease agreement for the hardware and software for a new business system with a total cost of approximately $335,000. The lease term is 54 months and requires monthly rental payments of $6,880 with an option to purchase the system at the end of the lease at its then estimated fair market value of $42,000. This fair market value can be paid in a lump sum at the termination date of the lease or paid in twelve equal monthly installments beginning in the month immediately following the last month of the initial lease term. If the Company elects not to purchase the system at the end of the lease, the terms of the lease will be extended for an additional six months at the same monthly rental payment called for during the initial lease term. This lease will be accounted for as a capital lease in accordance with SFAS No. 13, “Accounting for Leases.” Therefore, th e Company will record in its fiscal 2004 third quarter financial statements ended March 31, 2004 an asset and an obligation at an amount equal to the present value at the beginning of the lease term of the minimum lease payments to be made during the lease term.

	9

CRITICARE SYSTEMS, INC.

Management's Discussion and Analysis of

Results of Operations and Financial Condition

Six Months Ended December 31, 2003 and 2002

Results of Operations

Net sales for the six months ended December 31, 2003 were level from the same period in the prior year as strong fiscal second quarter sales in the current year nearly matched the Company’s record sales for the fiscal second quarter of the prior year. A 15.6% increase in the number of units shipped was offset by a 10.3% reduction in the average sales price per unit and a 20.3% decrease in accessory sales in the current period. The higher unit sales and lower average sales price per unit were driven by a large shipment of the Company’s 504DX pulse oximeters to supply a large government tender in Mexico. These units monitor pulse oximetry only and therefore carry a much lower average selling price than the Company’s equipment that monitors multiple vital signs parameters.

The gross profit percentage of 40.8% for the six months ended December 31, 2003 was down slightly from the 41.3% for the same period in the prior year. The slightly lower margins were more than offset by a $494,134 reduction in operating expenses from the same period in the prior year driven mainly by a $363,710 decrease in administrative expenses and a $161,342 decrease in research, development and engineering expenses. A $237,758 reduction in legal and consulting fees related to the internal review conducted in the prior year by the Company of its import and export procedures was the main contributor to the lower administrative expenses. In addition, a final payment in the prior year of $150,000 made to the Company’s former CEO and founder to satisfy past severance obligation issues increased expenses in the prior year period compared to the current year period. The lower research, development and engin eering expenses were mainly due to a $164,989 reduction in project spending as significant expenses were incurred in the prior year to launch the Company’s new line of proprietary anesthesia monitoring products.

Total other income for the six months ended December 31, 2003 decreased $285,488 from the same period in the prior year. Total other income in the prior year period included the recognition of a $255,842 gain on the sale of 54,000 shares of the Company’s Immtech International, Inc. stock, $100,000 in profits recognized on the completion of a medical equipment integration project in Romania, and a $41,208 gain on the sale of the Company’s building. These gains were partially offset by the elimination of $91 ,533 in interest expense in the current period due to the retirement of the long-term debt on the Company’s facility from the August 30, 2002 sale of its building.

The $494,134 reduction in operating expenses more than offset the $285,488 decrease in other income for the six months ended December 31, 2003, resulting in net income of $20,694 that was $132,174 better than the $111,480 net loss in the prior year period.

	10

CRITICARE SYSTEMS, INC.

Management's Discussion and Analysis of

Results of Operations and Financial Condition

Three Months Ended December 31, 2003 and 2002

Results of Operations

Strong fiscal second quarter sales of $8,980,277 for the three months ended December 31, 2003 nearly matched the Company’s record sales of $9,049,600 for the same period in the prior year. A 22.3% increase in the number of units shipped was offset by a 19.0% reduction in the average sales price per unit and a 9.6% decrease in accessory sales in the current period. As noted above, the higher unit sales and lower average sales price per unit were driven by a large shipment in the current quarter of the Company’s 504DX pulse oximeters to supply a large government tender in Mexico. These units monitor pulse oximetry only and therefore carry a much lower average selling price than the Company’s equipment that monitors multiple vital signs parameters.

The gross profit percentage of 41.0% for the three months ended December 31, 2003 decreased from the 43.5% produced in the same period in the prior year. A $214,223 combined increase in the charges for warranty and the obsolescence reserve compared to the same period in the prior year reduced margins.

A $590,300 reduction in operating expenses more than offset the lower margins, resulting in income from operations for the three months ended December 31, 2003 of $372,325 that was $336,769 better than the same period in the prior year. Administrative expenses decreased $307,738 due mainly to a $133,566 reduction in legal and consulting fees related to the internal review conducted in the prior year by the Company of its import and export procedures and a final payment made in the prior year of $150,000 to the Company’s former CEO and founder to satisfy past severance obligation issues. Research, development and engineering expenses were down $132,994 mainly due to lower project spending as significant expenses were incurred in the prior year to launch the Company’s new line of proprietary anesthesia monitoring products.

Total other income for the three months ended December 31, 2003 decreased $104,516 from the same period in the prior year. Total other income in the prior year included the recognition of $100,000 in profit on the completion of a medical equipment integration project in Romania and a $14,096 gain on the sale of 4,000 shares of the Company’s Immtech International, Inc. stock. An $8,900 increase in royalty income in the current period partially offset the other income items that were recognized in the prior year.

The strong sales and significant reduction in operating expenses more than offset the decrease in margins and lower other income, resulting in net income of $412,424 that was $232,253 better than the $180,171 of net income in the prior year period.

	11

CRITICARE SYSTEMS, INC.

Management's Discussion and Analysis of

Results of Operations and Financial Condition

Liquidity and Capital Resources

As of December 31, 2003, the Company had a cash balance of $3,847,088 that was $130,642 higher than its fiscal 2003 year-end balance at June 30, 2003 of $3,716,446. The Company continues to maintain a long-term bank debt free balance sheet since August 30, 2002 when it sold its building and used the proceeds from the sale to retire the long-term bank debt on the facility.

The Company increased its cash position by $130,642 for the six months ended December 31, 2003 as $357,034 of cash provided from the exercise of 200,850 shares of expiring stock options more than offset $244,272 of capital spending. Cash from operations was basically breakeven as non-cash charges totaling $691,943 and a $1,054,050 increase in total liabilities nearly offset a $1,766,507 increase in total receivables and prepaid expenses.

On January 19, 2004 the Company entered into a lease agreement for the hardware and software for a new business system. The lease term is 54 months and requires monthly rental payments of $6,880 with an option to purchase the system at the end of the lease at its then estimated fair market value of $42,000. This fair market value can be paid in a lump sum at the termination date of the lease or paid in twelve equal monthly installments beginning in the month immediately following the last month of the initial lease term. If the Company elects not to purchase the system at the end of the lease, the terms of the lease will be extended for an additional six months at the same monthly rental payment called for during the initial lease term. This lease will be accounted for as a capital lease in accordance with SFAS No. 13, “Accounting for Leases”. Therefore, the Company will record in its fiscal 2004 thi rd quarter financial statements ended March 31, 2004 an asset and an obligation at an amount equal to the present value at the beginning of the lease term of the minimum lease payments to be made during the lease term.

 

The Company believes all capital and liquidity requirements for the remainder of fiscal 2004 will be satisfied by cash generated from operations and its current cash balances. On November 15, 2003 the Company entered into a new credit agreement with its bank for a $2,500,000 line of credit that expires on November 15, 2004. The Company does not expect to utilize this credit facility during its term but it is available if necessary. At December 31, 2003, there were no borrowings outstanding under this line of credit.

Forward Looking Statements

A number of the matters and subject areas discussed herein that are not historical or current facts deal with potential future circumstances and developments. These include anticipated product introductions, expected future financial results, liquidity needs, financing ability, management's or the Company's expectations and beliefs and similar matters discussed in Management's Discussion and Analysis or elsewhere herein. The discussions of such matters and subject areas are qualified by the inherent risk and uncertainties surrounding future expectations generally, and also may materially differ from the Company's actual future experience.

	12

The Company's business, operations and financial performance are subject to certain risks and uncertainties which could result in material differences in actual results from management's or the Company's current expectations. These risks and uncertainties include, but are not limited to, general economic conditions, demand for the Company's products, costs of operations, the development of new products, the reliance on single sources of supply for certain components in the Company's products, government regulation, health care cost containment programs, the effectiveness of the Company's programs to manage working capital and reduce costs, competition in the Company's markets, compliance with product safety regulations and product liability and product recall risks, risks relating to international sales and compliance with U.S. export regulations, unanticipated difficulties in outsourcing the manufacturing of the majority of its products to foreign manufacturers and risks related to foreign manufacturing, including economic and political instability, trade and foreign tax laws, production delays and cost overruns and quality control.

 

Quantitative and Qualitative Disclosures about Market Risk

The Company has a demand line of credit facility with a commercial bank with interest payable monthly at 25 basis points above the bank's reference rate. The Company had no borrowings outstanding under this bank facility at December 31, 2003 and June 30, 2003. Due historically to the lack of need to borrow from this credit facility and due to the Company’s current cash position, the Company is not subject to financial risk on this obligation if interest rates in the market change significantly.

The Company’s net sales are primarily denominated in United States dollars, except for a small amount of net sales from the Company’s operation in India denominated in Indian rupees. As a result, part of the Company’s accounts receivable are denominated in rupees and translated into U.S. dollars for financial reporting purposes. A 10% change in the exchange rate of the U.S. dollar with respect to the Indian rupee would not have a material adverse effect on the Company’s financial condition or results of operations. The Company does not use any hedges or other derivative financial instruments to manage or reduce exchange rate risk.

Controls and Procedures

As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and the Company’s Vice President - Finance, of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on this evaluation, the Company’s Chief Executive Officer and Vice President - Finance concluded that the Company’s disclosure controls and procedures were effective in timely alerting them to material information relating to the Company required to be included in the Company’s periodic filings with the Securities and Exchange Commission. It should be noted that in designing and evaluating the disclosure controls and procedures, management recognized that any cont rols and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

	13

The Company has designed its disclosure controls and procedures to reach a level of reasonable assurance of achieving the desired control objectives and based upon the evaluation described above, the Company’s Chief Executive Officer and Vice President –Finance conclude that the Company’s disclosure controls and procedures were effective at reaching that level of reasonable assurance.

There was no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

	14

PART II - OTHER INFORMATION

Item 4. Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders of the Company was held on November 14, 2003. The matters voted upon, including the number of votes cast for, against or withheld, as well as the number of abstentions and broker non-votes, as to each such matter were as follows:

Proposal 1: Election of directors for a term ending at the 2006 annual meeting of stockholders.

	For	Withheld
Emil H. Soika	10,165,889	412,474
Stephen K. Tannenbaum	10,144,539	433,824

 

The Company's other directors consist of Higgins D. Bailey (whose term ends at the 2004 annual meeting of stockholders) and Jeffrey T. Barnes and N.C. Joseph Lai (whose terms end at the 2005 annual meeting of stockholders).

Proposal 2: Approval of the Criticare Systems, Inc. 2003 Stock Option Plan.

For	Against	Abstain	Broker Non-Votes
4,486,874	662,404	113,870	5,315,215

Proposal 3: Ratification of appointment of BDO Seidman, LLP as auditors of the Company.

For	Against	Abstain	Broker Non-Votes
10,371,764	187,982	18,617	0

Item 6. Exhibits and Reports on Form 8-K.

(a)       Exhibits:

3.1   Restated Certificate of Incorporation of the Company (incorporated by reference to the Registration Statement filed on Form S-1, Registration No. 33-13050).

 

3.2   By-Laws of the Company (incorporated by reference to the Registration Statement filed on Form S-1, Registration No. 33-13050).

 

 4.1  Specimen Common Stock certificate (incorporated by reference to the Registration Statement filed on Form S-1, Registration No. 33-13050).

 

4.2   Rights Agreement (incorporated by reference to the Company's Current Report on Form 8-K filed on April 18, 1997).

 

31.1  Certification of Emil H. Soika, President and Chief Executive Officer (Principal Executive Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2  Certification of Michael J. Sallmann, Vice President - Finance and Secretary (Principal Financial Officer) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32*  Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

__________________

* This Certification is not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(b)    Reports on Form 8-K: None in the quarter ended December 31, 2003.

	15

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CRITICARE SYSTEMS, INC.

(Registrant)

Date:  February 4, 2004      BY   /s/ Michael J. Sallmann                   

       Michael J. Sallmann

       Vice President - Finance

       (Chief Accounting Officer and

       Duly Authorized Officer)

	16